Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
ADA_ETA_BIO2021: real-world evaluation of adherence, persistence, and cost-effectiveness of originator and biosimilar biologic drugs in the treatment of rheumatoid arthritis: a multicenter study in Italy.
Santoleri F, Lasala R, Abrate P, Pestrin L, Pasut E, Modesti G, Musicco F, Fulgenzio C, Zuzolo E, Pieri G, Roperti M, Gazzola P, Gambera M, Martignoni I, Montresor V, De Vita F, Guarino F, Grossi L, Di Fabio L, Roberti C, Spoltore C, Tinari G, De Rosa S, Giannini R, Langella R, Mingolla G, Piccoli M, Costantini A. Santoleri F, et al. Among authors: pasut e. Curr Med Res Opin. 2023 Dec;39(12):1729-1735. doi: 10.1080/03007995.2023.2287600. Epub 2023 Dec 15. Curr Med Res Opin. 2023. PMID: 37994874
Adherence, persistence and treatment switching in psoriasis.
Santoleri F, Musicco F, Fulgenzio C, Abrate P, Pestrin L, Pasut E, Modesti G, Giannini R, Rosa S, Piccoli M, Mingolla G, Zuzolo E, Gazzola P, Roperti M, Pieri G, Montresor V, Martignoni I, Gambera M, Langella R, Tinari G, Spoltore C, Roberti C, Fabio LD, Grossi L, Guarino F, Vita F, Lasala R, Costantini A. Santoleri F, et al. Among authors: pasut e. Immunotherapy. 2024 Apr 23. doi: 10.2217/imt-2023-0343. Online ahead of print. Immunotherapy. 2024. PMID: 38651935
Prevalence of COVID-19 among patients with chronic inflammatory rheumatic diseases treated with biologic agents or small molecules: A population-based study in the first two months of COVID-19 outbreak in Italy.
Quartuccio L, Valent F, Pasut E, Tascini C, De Vita S. Quartuccio L, et al. Among authors: pasut e. Joint Bone Spine. 2020 Oct;87(5):439-443. doi: 10.1016/j.jbspin.2020.05.003. Epub 2020 May 20. Joint Bone Spine. 2020. PMID: 32445935 Free PMC article.
Prévalence du COVID-19 chez les patients atteints de rhumatismes inflammatoires chroniques traités par biothérapies ou inhibiteurs des JAK : une étude basée sur la population au cours des deux premiers mois de l’épidémie de COVID-19 en Italie.
Quartuccio L, Valent F, Pasut E, Tascini C, De Vita S. Quartuccio L, et al. Among authors: pasut e. Rev Rhum Ed Fr. 2021 Oct;88(5):377-381. doi: 10.1016/j.rhum.2021.05.004. Epub 2021 May 14. Rev Rhum Ed Fr. 2021. PMID: 34007141 Free PMC article. French.